Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.
Cripps, C
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 1999 - 1175-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0923-7534
10.1023/a:1008372529239 doi
Adenocarcinoma--drug therapy
Aged
Antineoplastic Agents--administration & dosage
Colorectal Neoplasms--drug therapy
Female
Glutamates--administration & dosage
Guanine--administration & dosage
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Palliative Care
Pemetrexed
Survival Analysis
Thymidylate Synthase--antagonists & inhibitors
Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 1999 - 1175-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0923-7534
10.1023/a:1008372529239 doi
Adenocarcinoma--drug therapy
Aged
Antineoplastic Agents--administration & dosage
Colorectal Neoplasms--drug therapy
Female
Glutamates--administration & dosage
Guanine--administration & dosage
Humans
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Palliative Care
Pemetrexed
Survival Analysis
Thymidylate Synthase--antagonists & inhibitors